REFERENCES
- Haskins K, Bradley B, Powers K, et al. Oxidative stress in type 1 diabetes. Ann NY Acad Sci. 2003; 1005: 43–54, [PUBMED], [INFOTRIEVE]
- Wan G H, Tsai S C, Chiu D TY. Decreased blood activity of glucose-6-phosphate dehydrogenase associates with increased risk for diabetes mellitus. Endocrine. 2002; 19: 191–195, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Griendling K K, Fitz Gerald G A. Oxidative stress and cardiovascular injury: Part II: animal and human studies. Circulation. 2003; 108: 2034–2040, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Smith T R, Miller M S, Lohman K K, Case L D, Hu J J. DNA damage and breast cancer risk. Carcinogenesis. 2003; 24: 883–889, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jacques P F, Taylor A. Micronutrients and age-related cataracts. Micronutrients in health and disease prevention., A Bendich, C E Butterworth. Marcel Dekker, New York 1991; 359–379
- Cheng A J, Chiu D TY, See L C, et al. Poor prognosis in nasopharyngeal cancer patients with low glucose-6-phosphate dehydrogenase activity. Jpn J Cancer Res. 2001; 92: 576–581, [PUBMED], [INFOTRIEVE], [CSA]
- Brennan M L, Penn M S, Van Lente F, et al. Prognostic value of myeloperoxidase in patients with chest pain. New Engl J Med. 2003; 349: 1595–1604, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Blankenberg S, Rupprecht H J, Bickel C, et al. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. New Engl J Med. 2003; 347: 1605–1613, [CSA], [CROSSREF]
- Schnabel R, Lackner K J, Rupprecht H J, et al. Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction: results from the AtheroGene study. J Am Coll Cardiol. 2005; 45(10)1631–1637, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Arese P, Deflora A. Pathophysiology of hemolysis in glucose-6-phosphate dehydrogenase deficiency. Semin Hematol. 1990; 27: 1–40, [PUBMED], [INFOTRIEVE], [CSA]
- Scott M D, Zuo L, Lubin B H, Chiu D TY. NADPH, not glutathione, status modulates oxidant sensitivity in normal and glucose-6-phosphate dehydrogenase-erythrocytes. Blood. 1991; 77: 2059–2064, [PUBMED], [INFOTRIEVE], [CSA]
- Liu T Z, Lin T F, Hung I J, Wei J S, Chiu D TY. Enhanced susceptibility of erythrocytes deficient in glucose-6-phosphate dehydrogenase to alloxan/GSH -induced decrease in red cell deformability. Life Sci. 1994; 55: 55–60, [CSA]
- Ho H Y, Cheng M L, Lu F J, et al. Enhanced oxidative stress and accelerated cellular senescence in glucose-6-phosphate dehydrogenase (G6PD) deficient human fibroblasts. Free Radic Biol Med. 2000; 29: 156–169, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cheng M L, Ho H Y, Liang C M, et al. Cellular glucose-6-phosphate dehydrogenase status modulates the effects of nitric oxide on human foreskin fibroblasts. FEBS Lett. 2000; 475: 257–262, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cheng M L, Ho H Y, Wu Y S, Chiu D TY. Glucose-6-phosphate dehydrogenase-deficient cells show an increased propensity for oxidant-induced senescence. Free Radic Biol Med. 2004; 36: 580–591, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Altomare E, Grattagliano I, Vendemiale G, et al. Oxidative protein damage in human diabetic eye: evidence of a retinal participation. Eur J Clin Invest. 1997; 27: 141–147, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Boscia F, Grattagliano I, Vendemiale G, Micelli-Ferrari T, Altomare E. Protein oxidation and lens opacity in humans. Invest Ophthalmol Vis Sci. 2000; 41: 2461–2465, [PUBMED], [INFOTRIEVE], [CSA]
- Donma O, Yorulmaz E, Pekel H, Suyugul N. Blood and lens lipid peroxidation and antioxidant status in normal individuals, senile and diabetic cataractous patients. Curr Eye Res. 2002; 25(1)9–16, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cheng H. Causes of cataract. Age, sugars, and probably ultraviolet B-radiation. Br Med J. 1989; 298: 1470–1471, [CSA]
- Westring D W, Pisciotta A V. Anemia, cataracts, and seizures in patients with glucose-6-phosphate dehydrogenase deficiency. Arch Intern Med. 1966; 118: 385–390, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Orzalesi N, Fossarello M, Sorcinelli R, Schlich U. The relationship between glucose-6-phosphate dehydrogenase deficiency and cataracts in Sardinia. An epidemiological and biochemical study. Doc Ophthalmol. 1984; 57: 187, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Moro F, Gorgone G, Li Volti S, et al. Glucose-6-phosphate dehydrogenase deficiency and incidence of cataract in Sicily. Am J Hum Genet. 1985; 5: 197–200, [CSA]
- Panich V, Na-Nakorn S. G6PD deficiency in senile cataracts. Hum Genet. 1980; 55: 123, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Huang C S, Hung K L, Huang M J, et al. Neonatal jaundice and molecular mutations in glucose-6-phosphate dehydrogenase deficient newborn infants. Am J Hematol. 1996; 51: 19–25, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tang T K, Yeh C H, Huang C S, Huang M J. Expression and biochemical characterization of human glucose-6-phosphate dehydrogenase in Escherichia coli: A system to analyze normal and mutant enzymes. Blood. 1994; 83: 1436–1441, [PUBMED], [INFOTRIEVE], [CSA]
- Chiu D TY, Zuo L, Chao L, et al. Characterization of glucose-6-phosphate dehydrogenase deficiency in patients of Chinese descent and identification of new base substitutions in the human G6PD gene. Blood. 1993; 81: 2150–2154, [PUBMED], [INFOTRIEVE], [CSA]
- Beutler E. Glucose-6-phosphate dehydrogenase deficiency. N Engl J Med. 1991; 324: 169–174, [PUBMED], [INFOTRIEVE], [CSA]
- Chiu D TY, Zuo L, Chen E, et al. Two commonly occurring nucleotide base substitutions in Chinese G6PD variants. Biochem Biophys Res Commun. 1991; 180: 988–993, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Chao L, Du C S, Louie E, et al. A to G substitution identified in exon 2 of the G6PD gene among G6PD deficient Chinese. Nucl Acid Res. 1991; 19: 6056, [CSA]
- Tseng C P, Huang C L, Chong K Y, Hung I J, Chiu D TY. Rapid detection of glucose-6-phosphate dehydrogenase gene mutations by denaturing high-performance liquid chromatography. Clin Biochem. 2005; 38: 973–980, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Chang J G, Chiou S S, Perng L I, et al. Molecular characterization of glucose-6-phosphate dehydrogenase (G6PD) deficiency by natural and amplification created restriction sites: five mutations account for most G6PD deficiency cases in Taiwan. Blood. 1992; 70: 1079–1082, [CSA]
- Lofgren S, Michael R, Soderberg P G. Impact of age and sex in ultraviolet radiation cataract in the rat. Invest Ophthalmol Vis Sci. 2003; 44: 1629–1633, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hayashi L C, Hayashi S, Yamaoka K, et al. Ultraviolet B exposure and type of lens opacity in ophthalmic patients in Japan. Sci Total Environ. 2003; 302: 53–62, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sasaki H, Jonasson F, Shiu Y B, et al. High prevalence of nuclear cataract in the population of tropical and subtropical areas. Dev Ophthalmol. 2002; 35: 60–69, [PUBMED], [INFOTRIEVE], [CSA]
- McCarty C A, Taylor H R. A review of the epidemiologic evidence linking ultraviolet radiation and cataracts. Dev Ophthalmol. 2002; 35: 21–31, [PUBMED], [INFOTRIEVE], [CSA]